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Background: Negative energy balance (NEB) is an altered metabolic state in high yielding cows that occurs during
the first few weeks postpartum when energy demands for lactation and maintenance exceed the energy supply
from dietary intake. NEB can, in turn, lead to metabolic disorders and to reduced fertility. Alterations in the
expression of more than 700 hepatic genes have previously been reported in a study of NEB in postpartum dairy
cows. miRNAs (microRNA) are known to mediate many alterations in gene expression post transcriptionally. To
study the hepatic miRNA content of postpartum dairy cows, including their overall abundance and differential
expression, in mild NEB (MNEB) and severe NEB (SNEB), short read RNA sequencing was carried out. To identify
putative targets of differentially expressed miRNAs among differentially expressed hepatic genes reported previously
in dairy cows in SNEB computational target identification was employed.
Results: Our results indicate that the dairy cow liver expresses 53 miRNAs at a lower threshold of 10 reads per million.
Of these, 10 miRNAs accounted for greater than 95% of the miRNAome (miRNA content). Of the highly expressed
miRNAs, miR-122 constitutes 75% followed by miR-192 and miR-3596. Five out of thirteen let-7 miRNA family members
are also among the highly expressed miRNAs. miR-143, down-regulated in SNEB, was found to have 4 putative
up-regulated gene targets associated with SNEB including LRP2 (low density lipoprotein receptor-related protein 2),
involved in lipid metabolism and up-regulated in SNEB.
Conclusions: This is the first liver miRNA-seq profiling study of moderate yielding dairy cows in the early postpartum
period. Tissue specific miR-122 and liver enriched miR-192 are two of the most abundant miRNAs in the postpartum dairy
cow liver. miR-143 is significantly down-regulated in SNEB and putative targets of miRNA-143 which are up-regulated in
SNEB, include a gene involved in lipid metabolism.
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miRNAs
miRNAs are among the most abundant and extensively
studied class of small non-coding RNA. miRNAs are es-
timated to regulate the expression of up to 60% of mam-
malian protein coding genes [1] and are associated with
many economically important traits in domestic live-
stock [2]. The biosynthesis of miRNA is comprised of
multiple stages. The initial stage involves transcription
of the miRNA gene to produce primary miRNAs, several
hundred base-pairs in length, followed by the generation* Correspondence: dermot.morris@teagasc.ie
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unless otherwise stated.of 70 nucleotide-long hairpin shaped pre-miRNAs. Finally,
Dicer-mediated processing results in the mature ~22
bp miRNA [3]. miRNA-mediated interference involves
imperfect base-pairing of miRNAs, typically to the 3' UTR
of the target mRNA. miRNAs have been reported to
regulate gene expression in various biological pathways
including those involved in metabolism and energy
homeostasis [4]. In addition, miRNAs have been impli-
cated in a wide variety of diseases [5,6]. The regulatory
role of miRNAs in liver disease such as hepatitis, diet in-
duced non-alcoholic fatty liver, alcoholic and non-
alcoholic hepatocellular carcinoma and cirrhosis have
been reported in humans and demonstrated in mouse
liver studies [7-9]. In the case of beef cows, both liver
specific and ubiquitously expressed miRNAs have been
reported [10,11]. In another cow liver study, miRNAsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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screening [12]. In addition, alterations in hepatic miRNAs
in lambs have been associated with periconceptional
changes in maternal nutrition [13].
Negative energy balance
The postpartum period is of critical importance for the
general and reproductive health of dairy cows [14]. Dur-
ing the early postpartum period energy expenditure for
maintenance and lactation exceeds energy intake from
nutrition resulting in NEB [15]. NEB increases the risk
of other metabolic disorders such as ketosis and fatty
liver and animals are prone to infectious diseases, in-
cluding mastitis, due to reduced immunity [16]. NEB
has profound effects on the liver, which undergoes many
physiological and biochemical changes to counteract the
energy imbalance [15,17]. An energy balance model of
early lactation dairy cows was developed previously
[18,19] resulting in two groups of cows with MNEB and
SNEB. Alterations in gene expression in the liver associ-
ated with SNEB have been reported in two previous
studies [19,20].
In the first study, 416 genes were found to be differen-
tially expressed due to SNEB using microarray-based
expression profiling [19]. In the second study, using
RNA-seq, 413 genes were shown to be differentially
expressed [20] with 72 differentially expressed genes in
common between the two studies. Both of these studies
report the alteration of genes involved in lipid metabol-
ism the main biological process altered during SNEB.
The mechanisms, however, mediating these alterations in
transciptome expression are yet to be fully understood.
In a microarray-based and RT-qPCR validated study of
liver miRNAs from this NEB model, five miRNAs were
found to be up-regulated in SNEB [21]. Microarray ex-
pression profiling, however, is limited to the pre-defined
probe sets on the array and only relative expression of
miRNAs can be measured. On the other hand with RNA
sequencing (RNA-seq) it is possible to measure the ex-
pression of all putative miRNAs in a sample [22]. As
miRNA activity and function depend on abundance [23],
accurate quantification of miRNA abundance is import-
ant [24,25]. miRNA sequencing is based on short read
RNA-seq and involves generation and high-throughput
sequencing of 50 bp cDNA reads derived from the small
RNA fraction of total RNA [26].
The objectives of this study were to (i) carry out an in-
depth global analysis of the hepatic miRNA content of
postpartum dairy cows, including their overall abun-
dance and differential expression, in MNEB and SNEB
using RNA sequencing and (ii) to computationally iden-
tify putative targets of differentially expressed miRNAs
among differentially expressed hepatic genes reported
previously in dairy cows in SNEB.Results
In total, more than 300 million reads were sequenced
from eight cDNA libraries. Of these, more than 292 mil-
lion reads passed quality control filters and just over 200
million reads aligned uniquely to Ensembl annotated
genes in the UMD_3.1 assembly of the bovine genome.
A summary of the data is provided in Table 1 and de-
tailed statistics in Additional file 1: Table S1. 99% of
reads, which aligned uniquely to the genome, aligned to
known miRNAs (Additional file 2: Table S2). The
UMD_3.1 build of the bovine genome has 26,618 anno-
tated genes and miRBase version 16 includes 792 Bos
taurus miRNAs including both pre and mature miRNAs.
There were 479 miRNAs for which at least one read was
observed in each of the eight samples in our dataset.
Out of these, 53 miRNAs were expressed above a mean
threshold of 10 reads per million (RPM) across all eight
samples.
The 10 most highly expressed miRNAs accounted for
more than 95% of all miRNAs expressed (Figure 1 and
Table 2). The liver miRNA expression profile was domi-
nated by miR-122, which accounted for 75% of all highly
expressed miRNAs. This was followed by miR-192 which
accounted for 8% and the let 7 family member miR-3596
which accounted for over 7% of the most abundantly
expressed miRNAs. The remaining seven most highly
abundant miRNAs were four members of the let 7 fam-
ily (let-7c, let-7i, let-7 g and let-7f-2) which accounted
for 3% while miR-140 accounted for ~1.5% and both
miR-29a and miR-423 made up ~0.5% each (Figure 1).
The most highly expressed liver miRNAs are all evolu-
tionary conserved and include five members of the 13-
member let-7 family (let-7c, let-7i, let-7 g, let-7f-2 and
miR-3596). These miRNAs were located across nine
different chromosomes with both let7-i and miR-3596
located on chromosome five. There was no evidence of
clustering of highly expressed miRNAs in a particular
genomic region. All are mature RNAs except for
let-7f-2 a stem-loop miRNA. The relative abundances,
sequences, genomic coordinates of highly expressed
miRNAs are given in Table 2. One miRNA, miR-143 was
differentially expressed between the SNEB and MNEB
groups. miR-143 was 3.2-fold down-regulated in the
SNEB group (FDR < 0.005) and was the 11th most abun-
dantly expressed (greater than 100,000 counts) miRNA
The direction and magnitude of miR-143 regulation was
confirmed (2.4-fold down-regulated) following RT-qPCR
validation (Table 3).
In order to identify genes that may be affected by the
down-regulation of miR-143 in SNEB, we computation-
ally predicted miRNA targets among the 3’UTRs of a
combined set of 757 hepatic genes that have been previ-
ously reported to be differentially expressed in the liver
tissues of the same animals [19,20]. A total of 4 genes
Table 1 Read statistics for SNEB and MNEB postpartum dairy cow liver miRNA-seq data
Sample* Processed
reads
Untrimmed
reads
Reads after
QC
Reads aligning to
UMD3.1.68†
Reads aligning uniquely
to UMD3.1.68
Reads aligning
to genes
7S 35,531,177 319,143 33,034,345 29,929,732 22,008,536 21,617,227
8S 42,701,190 212,634 42,060,747 39,510,950 28,788,096 28,526,343
9S 39,733,845 276,697 35,308,457 32,324,504 24,940,747 24,682,635
10S 37,834,521 326,905 34,658,341 31,140,804 22,754,746 22,477,046
2M 35,079,188 272,113 32,996,280 30,024,759 23,042,362 22,809,423
3M 44,401,783 289,778 43,107,430 40,269,999 30,931,375 30,757,376
4M 40,699,727 280,820 32,868,631 29,571,511 23,373,573 23,050,065
5M 38,751,887 198,345 38,079,095 36,361,987 34,268,099 33,963,761
Sum 314,733,318 2,176,435 292,113,326 269,134,246 210,107,534 207,883,876
Average 39,341,665 272,054 36,514,166 33,641,781 26,263,442 25,985,485
*S = SNEB; M=MNEB.
†UMD3.1.68 = Ensembl v68 annotation of the UMD3.1 assembly of the bovine genome.
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putative targets of miR-143 (Table 4). The biological
functions and intracellular location of these targets are
given in Table 5.Discussion
The postpartum increase in milk production in high
yielding dairy cows is accompanied by increased nutri-
tional and energetic demands. This results in 10–12
weeks of NEB in all high-yielding dairy cows [26]. Pre-
vious reports have shown that SNEB affects the exp-
ression of multiple genes in the liver, including genes
involved in lipid and glucose metabolism and homeosta-
sis [19,20]. Hepatic miRNAs have been reported to play
a role in hepatic functions and disorders in human and
mouse [27]. In addition miRNAs are reported to be as-
sociated with energy metabolism through their role in
modulation of glucose and lipid homeostasis [28,29].
The miRNA profile of MNEB and SNEB dairy cow liver
two weeks postpartum in this study shows some degree75
8
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Figure 1 The 10 most abundant hepatic miRNAs in the
postpartum dairy cow.of similarity with hepatic miRNA profiles of other ani-
mals including human, mouse, rat, and beef cows.
Abundantly expressed miRNAs in postpartum dairy
cow liver
This is the first liver miRNA-seq profiling study of moder-
ate yielding dairy cows in the first two weeks postpartum.
The most dominant among the ten highly abundant
miRNAs in our study, miR-122, is a liver-specific con-
served miRNA. This dominance of expression by miR-122
is consistent with previous studies in dairy [10] and beef
cows [11] where miR-122 was reported to be only
expressed in liver, when compared with other tissues, and
constituted more than 57% of all the miRNA reported in
liver [11]. In addition, miR-122 has been reported to ac-
count for 70% of the total miRNAs in human liver [30].
Tissue specific roles of miR-122 are well established in hu-
man and miR-122 has been implicated in the hepatic dis-
orders hepatocarcinogenesis and hepatocellular carcinoma
[9,31,32]. Furthermore, the antagonism of miR-122 was
reported to result in disruptions of cholesterol and lipid
metabolism in mice [9]. The second most abundant
miRNA in our study miR-192 has been associated with
cellular responses to glucose stimulus [33] and was
also reported to be one of the most highly expressed after
miR-122 in human liver miRNA studies [31,34] and in a
mouse liver study [35]. miR-192 unlike miR-122 is not a
liver specific miRNA and has also been reported to have
important roles in human and bovine renal tissues
and functions [36-38]. Five of the thirteen members of the
let-7 family are also highly expressed in this study includ-
ing let-7c, let-7i, let-7 g, miR-3596 and let-7-f. The let-7
family members have been associated with hepatic devel-
opment and disorders as well as glucose and insulin me-
tabolism [39]. Over-expression of let-7c in human liver
was implicated in hepatocytes oxidant injury [40] while
let-7 g was demonstrated to suppress HCC metastasis in a
Table 2 Highly expressed miRNAs in postpartum dairy cows
miRNAs miR family miRNA-seq counts Sequence Coordinates (UMD3.1.68)†
miR-122 miR-122 19364782 UGGAGUGUGACAAUGGUGUUUG chr24: 58095642–58095726 [+]
miR-192 miR-192 2083071 CUGACCUAUGAAUUGACAGCCAG chr29: 43731660–43731765 [+]
miR-3596 let 7 1902520 AACCACACAACCUACUACCUCA chr5: 117120188–117120270 [−]
miR-140 miR-140 385996 UACCACAGGGUAGAACCACGGA chr18: 37088137–37088230 [+]
bta-let-7c let 7 274368 UGAGGUAGUAGGUUGUAUGGUU chr1: 19930459–19930542 [−]
bta-let-7i let 7 179868 UGAGGUAGUAGUUUGUGCUGUU chr5: 51209081–51209164 [−]
bta-let-7 g let 7 150545 UGAGGUAGUAGUUUGUACAGUU chr22: 49189340–49189422 [+]
bta-let-7f-2 let 7 124091 UGUGGGAUGAGGUAGUAGAUUGUAUAGUUUUAGGGUCAUAC
CCCAUCUUGGAGAUAACUAUACAGUCUACUGUCUUUCCCACG
chrX: 96383532–96383614 [−]
miR-423 miR-423 116540 AAGCUCGGUCUGAGGCCCCUCAGU chr19: 21799484–21799577 [+]
miR-29a miR-29 115428 CUAGCACCAUCUGAAAUCGGUUA chr4: 95402319–95402382 [−]
†UMD3.1.68 = Ensembl v68 annotation of the UMD3.1assembly of the bovine genome.
Table 4 Up-regulated putative hepatic gene targets of
miR-143 in postpartum dairy cows in SNEB†
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highly expressed miRNAs in this study, has been reported
to be abundantly expressed in human and mouse liver
with implications in liver function and disorders [42-44].
Differentially expressed miRNAs in postpartum dairy cow
liver in SNEB
Only one miRNA, miR-143 was found to be differen-
tially expressed in this study using miRNA-seq and sub-
sequently validated by RT-qPCR. This may have been
due in part to the fact that most of the sequence reads
in this study came from a small number of miRNAs pos-
sibly limiting the power of RNA-seq to accurately esti-
mate the abundance of the more lowly expressed
miRNAs. Less abundant miRNAs would not be affected
to the same extent in a microarray based approach
which has probes corresponding to known miRNAs. In
a previous microarray-based study of the same animals,
ten miRNAs were found to be differentially expressed;
five of which were validated using RT-qPCR [21]. In this
study, one additional miRNA bta-miR-1247, would have
been declared differentially expressed were it not ex-
cluded from the analysis due to having read counts
below the lower threshold criterion of 10 reads per mil-
lion. In addition, in this study a cut-off of 18 nts in
length was used in the analysis, whereas in the micro-
array study, miR-1281 which was found to be differen-
tially expressed is 17 nts in length.
miR-143, a highly expressed miRNA in this study, is
down-regulated in SNEB. miR-143 is not liver-specific,Table 3 Differentially expressed miRNA in SNEB
postpartum dairy cow liver validated using RT-qPCR
Ensemble gene miRBase ID FC FDR
ENSBTAG00000030114 bta-mir-143 −2.40 0.029
Differential expression analysis was carried out with PROC t-test (SAS) after
normalization of Ct-values to reference gene RNU6B.however its tissue-enriched expression has been re-
ported in human [45] chicken [46], rat [43] and mouse
[47,48] liver. In the case of human, miR-143 has been
implicated in hepatocellular carcinoma. In the rat study,
miR-143 was demonstrated to regulate activation and
proliferation of myofibroblastic hepatic stellate cells
(HSC) while in the mouse study miR-143 was shown to
regulate glucose metabolism in vitro, and was associated
with hepatic insulin regulation. In addition, miR-143 has
been found to be ubiquitously expressed in bovine tis-
sues including liver [10] and has also been associated
with bovine intramuscular fat proliferation and differen-
tiation [49] and high back fat deposition in crossbred
beef cattle [50].
Some important predicted gene targets of miRNA
miR-143
Of the 4 putative targets of miR-143 which have been re-
ported previously to be up-regulated in SNEB, LRP2 is
involved in lipid metabolism and is of particular interest
because the metabolism of lipids is altered during SNEB
[51,52]. LRP2 is implicated in lipid metabolism through
its role as a receptor for sterols, steroid hormones bound
to carrier proteins [53] like lipoproteins [54] and apoli-
poprotein M of liver [55-57]. A study of miRNA based
modulation of obesity also reported LRP2 as a putative
target of miR-130a, with roles in lipid metabolism [58].Human gene name Fold change FDR
CHRM1 4.3 0.004222
LRP2 3.28 0.015161
ARHGEF40 2.85 1.34E-06
C6orf145 2.1 1.02E-06
†From Mc Carthy et al., [19]; McCabe et al., [20].
Table 5 Functional categories of up-regulated putative target hepatic genes of miR-143†
ID Symbol Entrez gene name Location Type(s)
CHRM1 CHRM1 cholinergic receptor, muscarinic 1 Plasma Membrane G-protein coupled receptor
LRP2 LRP2 low density lipoprotein receptor-related protein 2 Plasma Membrane Transporter
ARHGEF40 ARHGEF40 Rho guanine nucleotide exchange factor (GEF) 40 unknown Enzyme
C6orf145 PXDC1 PX domain containing 1 unknown Signalling protein
†Target genes are those predicted using both TargetScan and miRanda.
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From a global examination of miRNA expression in the
liver of postpartum dairy cattle ten highly expressed
miRNAs dominate. Tissue specific miR-122 and liver
enriched miR-192 are two of the most abundant miR-
NAs in the postpartum dairy cow liver. miR-143 is sig-
nificantly down-regulated in SNEB and putative targets
of miRNA-143 up-regulated in SNEB, include LRP2 a
good candidate as a potential mediator of the metabolic
effects of NEB.
Methods
NEB model
A NEB dairy cow model developed previously was used.
In this model differential feeding and milking regimes
were used to produce two groups of Holstein Friesian
cows; MNEB and SNEB [18,19]. Briefly, MNEB cows
were fed ad libitum grass silage with 8 kg/day of a 21%
crude protein dairy concentrate and milked once daily.
SNEB cows were fed 25 kg/day silage with 4 kg/day con-
centrate and milked thrice daily.
Liver tissue collection for miRNA analysis
All procedures were carried out under license in accord-
ance with the European Community Directive, 86-609-EC.
Cows were slaughtered approximately 14 days postpar-
tum (MNEB; 13.6 ± 0.75, range 11–15; SNEB 14.3 ±
0.56, range 13–16) and the entire liver was removed
within 15 to 30 min [19]. Samples weighing approxi-
mately 1 g were dissected, rinsed in RNAase-free phos-
phate buffer, snap-frozen in liquid nitrogen and stored
at -80°C. Liver tissue samples from 4 animals from each
group were used for miRNA library preparation.
RNA extraction and library preparation
Total RNA enriched for small RNA was extracted from
1 mg of frozen tissue from each of the eight samples
using the mirVana™ miRNA Isolation Kit (Life Technolo-
gies, Carlsbad, CA, USA) according to the manufac-
turer’s protocol. The RNA extract was stored at −80°C.
An Agilent RNA 6000 Nano Kit and the 2100 Bioanaly-
zer was used to measure total RNA integrity (Agilent
Technologies, Colorado Springs, CO, USA) and the
Agilent Small RNA Kit (Agilent Technologies) was used
for miRNA quantification. Small RNA libraries wereconstructed at BGI (Shenzhen, China) under contract
and sequenced on an Illumina HiSeq2000 platform.
Data analysis pipeline
FASTQC v0.10.0 (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/) was used to carry out preliminary
quality control of the 8 FASTQ files. The 3′ adaptor se-
quences were trimmed with Cutadapt v1.1 (https://code.
google.com/p/cutadapt). After trimming, reads shorter
than 18 nucleotides were discarded. The FASTQ quality
filter v0.0.13 (http://hannonlab.cshl.edu/fastx_toolkit/) was
applied to trim low quality bases from reads. Phred scores
were calculated and reads where at least 50% of the bases
had a Phred score of less than 20 were discarded [59]. The
filtered reads were further trimmed at their ends to remove
low quality bases (Phred score <20). Reads were then
aligned to the bovine genome (UMD3.1) using Novoalign
version 2.07.11 (http://www.novocraft.com) using the “-m”
miRNA mode. Only uniquely aligned reads were retained.
HTSeq version 0.5.3p3 (http://www-huber.embl.de/users/
anders/HTSeq/doc/overview.html) was used to annotate
uniquely aligned reads using Ensembl (v68) bovine gene
and miRNA annotation.
Differential expression analysis
As differential expression analysis of miRNAseq data is
sensitive to the normalisation method a number of alter-
native methods were used [60]. Differential expression was
assessed following normalisation of count data using
either the trimmed mean of M-values (TMM), the upper
quartile-normalisation method or no normalisation using
the Bioconductor package EdgeR (v2.4.6). EdgeR which
uses a negative binomial model to account for both bio-
logical and technical variability was used to identify differ-
entially expressed miRNAs between the two groups using
moderated tag wise dispersions. A Benjamini and Hoch-
berg [61] corrected P value cut-off of <0.05 was applied to
correct for multiple testing. Only miRNAs expressed above
a threshold of 10 reads per million were considered for
the differential expression analysis as miRNAs expressed
below this threshold are unlikely to be functional.
RT-qPCR validation of differentially expressed miRNAs
RT-qPCR was used for technical validation of differen-
tially expressed miRNA using TaqMan miRNA assay
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verse transcription was performed on 10 ng of purified
total RNA using the TaqMan MicroRNA Reverse Tran-
scription kit according to manufacturer’s instructions
(Applied Biosystems, Dublin, Ireland). RT-qPCR reac-
tions were performed using 1 μl of cDNA (10 ng/μl) in
9 μl of Taqman universal master mix containing TaqMan
PCR primers and probes on a BioRad CFX96 real time
PCR system (Bio-Rad, United Kingdom) using the fol-
lowing cycling parameters: 95°C for 10 min followed by
40 cycles at 95°C for 15 s and 60°C for 1 min. A total of
four biological replicates from each of the MNEB and
SNEB treatment groups were used for RT-qPCR valid-
ation. From prior experience with microarray hepatic
miRNA expression validation and using the same liver
tissue samples from the same animals, RNU6B was
chosen as the most stable internal reference miRNA
[21]. miRNA expression levels were recorded as Ct
values, i.e., the number of PCR cycles at which the fluor-
escence signal is detected above the threshold value.
The software package BioRad CFX manager was used
for correction of the Ct values and normalization to
RNU6B using the 2-ΔΔCt method [62]. Corrected Ct
values were used to calculate differential expression using
the PROC t-test (SAS) [63]. A P < 0.05 was deemed to be
significant.MiRNA target predictions
Both TargetScan Release 6.2 (www.targetscan.org) [1,64,65]
and miRanda v4.0 (www.microrna.org) [66] were used to
predict common targets of differentially expressed miR-
NAs among the two datasets of up-regulated hepatic
genes previously reported for liver tissues from the same
cows [19,20].Availability of supporting data
The data sets supporting the results of this article are avail-
able in Gene Expression Omnibus (GEO) repository
GSE55882 http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?
acc=GSE55882.Additional files
Additional file 1: Table S1. Detailed summary of RNA-seq data for
postpartum dairy cow liver.
Additional file 2: Table S2. Percentage distribution of RNA biotypes.
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